Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BASI NASDAQ:CBLI OTCMKTS:CBWTF NASDAQ:ELOX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBASIBioanalytical Systems$0.25+0.4%$18.71$3.05▼$21.08$2.82M1.92122,925 shs572,125 shsCBLICleveland BioLabs$3.19$1.62▼$10.97$6K0.7271,922 shs3,245 shsCBWTFCannabis Wheaton Income$0.12+5.9%$0.10$0.05▼$0.14$169.84M1.39635,687 shs927,609 shsELOXEloxx Pharmaceuticals$12.01-18.3%$16.91$12.00▼$17.50$8.29M-1932.8811,859 shs15,863 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBASIBioanalytical Systems0.00%0.00%0.00%-29.81%-88.58%CBLICleveland BioLabs0.00%0.00%0.00%0.00%+33.33%CBWTFCannabis Wheaton Income0.00%+1.82%+10.34%+13.25%+86.05%ELOXEloxx Pharmaceuticals+8.73%-67.17%-30.58%+121,387.60%+1,469,999,900.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBASIBioanalytical Systems$0.25+0.4%$18.71$3.05▼$21.08$2.82M1.92122,925 shs572,125 shsCBLICleveland BioLabs$3.19$1.62▼$10.97$6K0.7271,922 shs3,245 shsCBWTFCannabis Wheaton Income$0.12+5.9%$0.10$0.05▼$0.14$169.84M1.39635,687 shs927,609 shsELOXEloxx Pharmaceuticals$12.01-18.3%$16.91$12.00▼$17.50$8.29M-1932.8811,859 shs15,863 shsTen Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBASIBioanalytical Systems0.00%0.00%0.00%-29.81%-88.58%CBLICleveland BioLabs0.00%0.00%0.00%0.00%+33.33%CBWTFCannabis Wheaton Income0.00%+1.82%+10.34%+13.25%+86.05%ELOXEloxx Pharmaceuticals+8.73%-67.17%-30.58%+121,387.60%+1,469,999,900.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBASIBioanalytical Systems 0.00N/AN/AN/ACBLICleveland BioLabs 0.00N/AN/AN/ACBWTFCannabis Wheaton Income 0.00N/AN/AN/AELOXEloxx Pharmaceuticals 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBASIBioanalytical Systems$60.47M0.05$0.00 per share558.40$0.69 per share0.37CBLICleveland BioLabs$260K0.00N/AN/A$0.87 per share0.00CBWTFCannabis Wheaton Income$108.41M1.57$0.03 per share4.01$0.09 per share1.32ELOXEloxx Pharmaceuticals$6.36M1.30N/AN/A($85.17) per share-0.14Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBASIBioanalytical Systems-$4.68M-$0.35N/A6.34N/A-7.75%-42.74%-6.38%N/ACBLICleveland BioLabs-$2.40MN/AN/AN/AN/AN/A-32.84%-31.29%N/ACBWTFCannabis Wheaton Income$29.96M$0.025.93N/AN/A20.99%19.84%12.26%N/AELOXEloxx Pharmaceuticals-$5.99MN/AN/AN/AN/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthBASIBioanalytical SystemsN/AN/AN/AN/AN/ACBLICleveland BioLabsN/AN/AN/AN/AN/ACBWTFCannabis Wheaton IncomeN/AN/AN/AN/AN/AELOXEloxx PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBASIBioanalytical Systems2.490.480.46CBLICleveland BioLabsN/A45.9345.93CBWTFCannabis Wheaton Income0.212.231.35ELOXEloxx PharmaceuticalsN/A0.530.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBASIBioanalytical Systems10.62%CBLICleveland BioLabs5.09%CBWTFCannabis Wheaton IncomeN/AELOXEloxx Pharmaceuticals2.90%Insider OwnershipCompanyInsider OwnershipBASIBioanalytical Systems11.46%CBLICleveland BioLabs1.03%CBWTFCannabis Wheaton Income4.60%ELOXEloxx Pharmaceuticals25.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBASIBioanalytical Systems39711.13 millionN/ANot OptionableCBLICleveland BioLabs415.48 millionN/ANot OptionableCBWTFCannabis Wheaton Income3691.43 billion1.37 billionNot OptionableELOXEloxx PharmaceuticalsN/A690,000510,000N/ABASI, CBWTF, ELOX, and CBLI HeadlinesRecent News About These CompaniesNo headlines for this company have been tracked by MarketBeat.comNew MarketBeat Followers Over Time Top HeadlinesView All HeadlinesSpaceX Gets the Attention, But These 4 Stocks Could Get the ReturnsBy Bridget Bennett | May 25, 20265 Stocks Winning the AI Race While Everyone Watches NVIDIABy Bridget Bennett | May 26, 2026The Smart Glasses Gold Rush Is Leaving Old-School Eyewear BehindBy Jeffrey Neal Johnson | May 24, 20263 Space Infrastructure Stocks Gaining Momentum Ahead of the SpaceX IPOBy Ryan Hasson | May 20, 2026Oil Could Dip, But These 3 Energy Stocks Still Look Built to WinBy Chris Markoch | June 15, 2026BASI, CBWTF, ELOX, and CBLI Company DescriptionsBioanalytical Systems NASDAQ:BASIBioanalytical Systems, Inc., doing business as Inotiv, provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment provides analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to identify and measure drug and metabolite concentrations in complex biological matrices; in vivo sampling services for the continuous monitoring of chemical changes in life; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; non-clinical toxicology and pathology services; and climate-controlled archiving services for its customers' data and samples. The Research Products segment designs, develops, manufactures, and markets in vivo sampling systems and accessories, including disposables, training, and systems qualification; physiology monitoring tools; liquid chromatography and electrochemistry instruments platforms; analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; and in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments. The company operates in the United States, rest of North America, the Pacific Rim, Europe, and internationally. BioVaxys has an agreement with Inotiv to conduct preclinical toxicity studies for its Covid-T Immunodiagnostic program. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.Cleveland BioLabs NASDAQ:CBLICytocom, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel small molecule immunotherapies. Its product applies to autoimmune, inflammatory, infectious diseases and cancers. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Fort Collins, CO.Cannabis Wheaton Income OTCMKTS:CBWTF$0.12 +0.01 (+5.89%) As of 12:56 PM EasternAuxly Cannabis Group Inc. operates as a consumer packaged goods company in the cannabis products market in Canada. It focuses on developing, manufacturing, and distributing cannabis products for wellness and recreational consumers. The company offers cannabis products under various forms, including vape catridges, infused pre-rolls, pre-rolled, vape pens, milled and dried flower, concentrates, chocolates, soft chews, oil drops, capsules, and topicals under the KOLAB PROJECT, Dosecann, BACK FORTY, Foray, and Parcel brand names. It sells its products through supply arrangements with provincial control boards and distributors, medical cannabis sales channels, and retailers, as well as to authorized wholesalers. The company was formerly known as Cannabis Wheaton Income Corp. and changed its name to Auxly Cannabis Group Inc. in June 2018. The company was incorporated in 1987 and is headquartered in Toronto, Canada.Eloxx Pharmaceuticals NASDAQ:ELOX$12.01 -2.69 (-18.30%) As of 12:49 PM EasternEloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engaged in developing novel small molecule medicines to treat many rare and ultra-rare genetic diseases caused by nonsense mutations. The company's lead product candidate consists ELX-02, is an optimized aminoglycoside designed to restore full-length functional proteins. It operates primarily in Waltham, MA and Rehovot, Israel. Eloxx Pharmaceuticals Inc., formerly known as Sevion Therapeutics Inc., is based in WALTHAM, United States. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Plot Twist: How the $110B Paramount-Warner Deal Rewrites Media Insiders Sell Top Tech Plays: Should Investors Buy, Sell, or Hold? What's Behind the Social Media Controversy Surrounding IonQ? This Golden Cross Could Send Urban Outfitters to New Highs Mission Control: Floating In SpaceX's Record-Breaking Orbit 3 Dividend Increases Investors Can Actually Trust RH’s Strong Q1 Still Leaves Investors With One Big Question SpaceX Rings the Bell and Shatters Every Record Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
